Diasorin Italia will launch the COVID-19 antibody test at the end of April | Instant News

A man wearing a face mask sits at a bus stop, when the spread of coronavirus (COVID-19) continues, in Milan, Italy April 6, 2020. REUTERS / Daniele Mascolo

MILAN (Reuters) – Italian medical diagnostic group Diasorin said on Tuesday that it aims to launch a new serological test to detect antibodies in patients infected with the new corona virus in late April.

Diasorin said he had completed his studies and was working to get the EU CE marking scheme and authorization from the US Food and Drug Administration (FDA) at the end of this month.

Some academic laboratories and medical companies rushed to produce this blood test, which can quickly identify disease-fighting antibodies in people who are already infected.

“This product has been designed to respond to the need to identify people in populations who have been infected with the virus, where the diagnosis has not been carried out with swabs and molecular diagnostic tests,” Diasorin said in a statement.

Diasorin has launched a molecular test to quickly identify new corona viruses.

Six weeks after the coronavirus outbreak in the country, authorities in northern Italy have begun testing health workers for antibodies that can help identify individuals with immunity to the virus when they look for ways to ease the locking that was put in place a month ago to contain the epidemic.

Diasorin’s shares rose more than 6% in early trading.

Reporting by Elisa Anzolin; editing by Jason Neely


image source

to request modification Contact us at Here or [email protected]

Leave a Reply

Your email address will not be published.